Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Implications of maternal obesity on fetal growth and the role of ultrasound|
|Citation:||Expert Review of Endocrinology and Metabolism, 2017; 12(1):45-58|
|Publisher:||Taylor & Francis|
|Cecelia M O'brien, Amanda Poprzeczny, Jodie M Dodd|
|Abstract:||Introduction: Over fifty percent of women entering pregnancy are overweight or obese. This has a significant impact on short and long term maternal and infant health outcomes, and the intergenerational effects of obesity are now a major public health problem globally. Areas covered: There are two major pathways contributing to fetal growth. Glucose and insulin directly affect growth, while other substrates such as leptin, adiponectin and insulin-like growth factors indirectly influence growth through structural and morphological effects on the placenta, uteroplacental blood flow, and regulation of placental transporters. Advances in ultrasonography over the past decade have led to interest in the prediction of the fetus at risk of overgrowth and adiposity utilizing both standard ultrasound biometry and fetal body composition measurements. However, to date there is no consensus regarding the definition of fetal overgrowth, its reporting, and clinical management. Expert commentary: Maternal dietary intervention targeting the antenatal period appear to be too late to sufficiently affect fetal growth. The peri-conceptual period and early pregnancy are being evaluated to determine if the intergenerational effects of maternal obesity can be altered to improve newborn, infant and child health.|
|Keywords:||Obesity; pregnancy; fetal growth; fetal body composition; adiposity|
|Rights:||© 2016 Informa UK Limited, trading as Taylor & Francis Group|
|Appears in Collections:||Medicine publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.